Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. BioCryst Pharmaceuticals

    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    270 Million USD
    Annual Operating Income in USD
    -148 Million USD
    Annual Net Income in USD
    -247 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
    Company Website
    BIOCRYST PHARMACEUTICALS
    Wikipedia
    Wikipedia

  2. Scholar Rock Holding Corporation

    World Rank (Jan-05-2024)
    7,601
    Market Cap (Jan-05-2024)
    1.234 Billion USD
    World Rank (Jul-30-2023)
    14,424
    Market Cap (Jul-30-2023)
    0.381 Billion USD
    World Rank (Dec-25-2022)
    13,681
    Market Cap (Dec-25-2022)
    0.412 Billion USD
    World Rank (Jan-07-2022)
    11,021
    Market Cap (Jan-07-2022)
    0.75 Billion USD
    Annual Revenue in USD
    18 Million USD
    Annual Net Income in USD
    -131 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Scholar Rock Holding Corporation is a Unique Technology Platform and insights to discover new medicines that break through barriers and find optimal solutions company. The headquarters is in USA.
    Company Website
    SCHOLAR ROCK HOLDING CORPORATION

  3. Kura Oncology

    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -139 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

  4. ADMA Biologics

    World Rank (Jan-05-2024)
    8,463
    Market Cap (Jan-05-2024)
    1.024 Billion USD
    World Rank (Jul-30-2023)
    9,311
    Market Cap (Jul-30-2023)
    0.896 Billion USD
    World Rank (Dec-25-2022)
    9,556
    Market Cap (Dec-25-2022)
    0.806 Billion USD
    World Rank (Jan-07-2022)
    17,664
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    154 Million USD
    Annual Operating Income in USD
    -39 Million USD
    Annual Net Income in USD
    -66 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ADMA BIOLOGICS

  5. Immatics N.V.

    World Rank (Jan-05-2024)
    9,099
    Market Cap (Jan-05-2024)
    0.908 Billion USD
    World Rank (Jul-30-2023)
    8,838
    Market Cap (Jul-30-2023)
    0.980 Billion USD
    World Rank (Dec-25-2022)
    10,806
    Market Cap (Dec-25-2022)
    0.649 Billion USD
    World Rank (Jan-07-2022)
    11,036
    Market Cap (Jan-07-2022)
    0.75 Billion USD
    Headquarters Country
    Germany
    Company Website
    IMMATICS N.V.

  6. Ambrx Biopharma Inc.

    World Rank (Jan-05-2024)
    9,402
    Market Cap (Jan-05-2024)
    0.858 Billion USD
    World Rank (Jul-30-2023)
    9,230
    Market Cap (Jul-30-2023)
    0.909 Billion USD
    World Rank (Dec-25-2022)
    24,053
    Market Cap (Dec-25-2022)
    0.063 Billion USD
    World Rank (Jan-07-2022)
    17,234
    Market Cap (Jan-07-2022)
    0.27 Billion USD
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile

    Ambrx is Biotechnology company with headquarters is in USA.

    Their mission is to discover and develop a pipeline of Engineered Precision Biologics to treat a broad range of diseases and disorders, with an initial focus on cancers with a high unmet medical need.

    Company Website
    AMBRX BIOPHARMA INC.

  7. Editas Medicine

    World Rank (Jan-05-2024)
    9,928
    Market Cap (Jan-05-2024)
    0.779 Billion USD
    World Rank (Jul-30-2023)
    10,632
    Market Cap (Jul-30-2023)
    0.707 Billion USD
    World Rank (Dec-25-2022)
    11,186
    Market Cap (Dec-25-2022)
    0.608 Billion USD
    World Rank (Jan-07-2022)
    6,883
    Market Cap (Jan-07-2022)
    1.72 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Operating Income in USD
    -225 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Editas Medicine is a Biotechnology company. It is a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. The company discover, develop, manufacture, and commercialize transformative, durable and precise genomic medicines for a broad class of diseases. The headquarters is in USA.
    Company Website
    EDITAS MEDICINE INC

  8. REGENXBIO Inc.

    World Rank (Jan-05-2024)
    10,026
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,791
    Market Cap (Jul-30-2023)
    0.818 Billion USD
    World Rank (Dec-25-2022)
    8,565
    Market Cap (Dec-25-2022)
    0.963 Billion USD
    World Rank (Jan-07-2022)
    8,285
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -262 Million USD
    Annual Net Income in USD
    -280 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    REGENXBIO is a Clinical Stage Biotechnology company. The company currently developing gene therapy product candidates for the treatment of retinal, metabolic and neurodegenerative diseases and provide long lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes. The headquarters is in USA.
    Company Website
    REGENXBIO INC

  9. Exscientia PLC

    World Rank (Jan-05-2024)
    10,187
    Market Cap (Jan-05-2024)
    0.745 Billion USD
    World Rank (Jul-30-2023)
    8,949
    Market Cap (Jul-30-2023)
    0.956 Billion USD
    World Rank (Dec-25-2022)
    11,931
    Market Cap (Dec-25-2022)
    0.537 Billion USD
    World Rank (Jan-07-2022)
    5,579
    Market Cap (Jan-07-2022)
    2.42 Billion USD
    Headquarters Country
    UK
    Company Profile
    Exscientia plc is a biotechnology company with automate drug design and are the first to have an AI Designed molecule enter clinical trials. The company annual revenue is 9.6 million GBP and total assets are 77.7 million GBP as on 2020. The headquarters is in UK.
    Company Website
    EXSCIENTIA PLC

  10. Adaptive Biotechnologies Corporation

    World Rank (Jan-05-2024)
    10,807
    Market Cap (Jan-05-2024)
    0.673 Billion USD
    World Rank (Jul-30-2023)
    7,981
    Market Cap (Jul-30-2023)
    1.165 Billion USD
    World Rank (Dec-25-2022)
    8,035
    Market Cap (Dec-25-2022)
    1.073 Billion USD
    World Rank (Jan-07-2022)
    4,537
    Market Cap (Jan-07-2022)
    3.27 Billion USD
    Annual Revenue in USD
    185 Million USD
    Annual Operating Income in USD
    -200 Million USD
    Annual Net Income in USD
    -200 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Adaptive Biotechnologies Corporation is a Life Science Equipment and Technology company. The company products and services of both current and pipeline, supporting life sciences research, clinical diagnostics and drug discovery, aim is to add an entirely new dimension to the diagnosis and treatment of disease from cancer to autoimmune conditions to infectious diseases. The headquarters is in USA.

    Company Website
    ADAPTIVE BIOTECHNOLOGIES CORPORATION

Share